Clinical Data With Pacritinib in Patients With Myelofibrosis
Centering discussion on the JAK inhibitor pacritinib, expert panelists review data from recent clinical trials and consider how they inform real-world use of this agent.
Data With Pacritinib Patients With Myelofibrosis Mf Cancer Primary Myelofibrosis Jak Inhibitors Jak Inhibition
Source: onclive.com